🇺🇸 FDA

Company profile · Sponsor

vTv

vTv Therapeutics

VTVT · NYSE pharma HIGH POINT, NC, USA
Pipeline
14
Drugs
0
Patents
8

Quick answer

vTv (VTVT) is a pharma company. headquartered in HIGH POINT, NC, USA. listed on NYSE. NovaPharmaNews links 14 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker VTVT
Exchange NYSE
Company type pharma
Headquarters HIGH POINT, NC, USA
SEC CIK 0001641489

Pipeline (14)

Search pipeline →

  1. Azeliragon

    vTv

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  2. Azeliragon 5mg

    vTv

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  3. Cadisegliatin 800 mg QD

    vTv

    Diabetes Mellitus, Type 1

    phase 3 small molecule active

    1 trial

  4. Azeliragon

    vTv

    Alzheimer Disease

    phase 2 small molecule terminated

    1 trial

  5. GK1-399 (formerly TTP399)

    vTv

    Type 2 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial

  6. TTP054

    vTv

    Type 2 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial

  7. TTP273

    vTv

    Type 2 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial

  8. TTP399

    vTv

    Diabetes Mellitus, Type 1

    phase 2 small molecule completed

    1 trial

  9. TTP399 400 mg

    vTv

    Diabetes Mellitus, Type 2

    phase 2 small molecule completed

    1 trial

  10. TTP435

    vTv

    Obesity

    phase 2 small molecule completed

    1 trial

  11. TTP889

    vTv

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial

  12. TTP889

    vTv

    Coagulation

    phase 2 small molecule terminated

    1 trial

  13. TTP4000

    vTv

    Alzheimer's Disease

    phase 1 small molecule completed

    1 trial

  14. TTP607

    vTv

    Advanced Cancers

    phase 1 small molecule terminated

    1 trial

Patents (8)

Search patents →

  1. US 12391658

    Sulfoxide and sulfone glucokinase activators and methods of use thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12091407

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11974989

    Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11970457

    Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11883383

    Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11833136

    Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11649230

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11524942

    Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine

    Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is vTv?

vTv (VTVT) is a pharma company. headquartered in HIGH POINT, NC, USA. listed on NYSE. NovaPharmaNews links 14 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does vTv sponsor?

We track 14 ClinicalTrials.gov-linked programs for vTv, including Azeliragon and 13 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does vTv company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.